- Home
- ETON vs BCAL Comparison
ETON vs BCAL Comparison
Compare ETON & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- BCAL
- Stock Information
- Founded
- ETON 2017
- BCAL 2001
- Country
- ETON United States
- BCAL United States
- Employees
- ETON N/A
- BCAL N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- BCAL Major Banks
- Sector
- ETON Health Care
- BCAL Finance
- Exchange
- ETON Nasdaq
- BCAL Nasdaq
- Market Cap
- ETON 428.5M
- BCAL 464.0M
- IPO Year
- ETON 2018
- BCAL N/A
- Fundamental
- Price
- ETON $17.07
- BCAL $15.25
- Analyst Decision
- ETON Strong Buy
- BCAL Strong Buy
- Analyst Count
- ETON 3
- BCAL 1
- Target Price
- ETON $27.67
- BCAL $20.00
- AVG Volume (30 Days)
- ETON 231.3K
- BCAL 92.2K
- Earning Date
- ETON 05-13-2025
- BCAL 04-24-2025
- Dividend Yield
- ETON N/A
- BCAL N/A
- EPS Growth
- ETON N/A
- BCAL N/A
- EPS
- ETON N/A
- BCAL 0.62
- Revenue
- ETON $39,011,000.00
- BCAL $132,045,000.00
- Revenue This Year
- ETON $92.33
- BCAL $77.37
- Revenue Next Year
- ETON $54.19
- BCAL $4.87
- P/E Ratio
- ETON N/A
- BCAL $24.49
- Revenue Growth
- ETON 23.29
- BCAL 42.63
- 52 Week Low
- ETON $3.18
- BCAL $11.87
- 52 Week High
- ETON $18.41
- BCAL $18.49
- Technical
- Relative Strength Index (RSI)
- ETON 62.16
- BCAL 66.68
- Support Level
- ETON $16.43
- BCAL $14.35
- Resistance Level
- ETON $17.74
- BCAL $15.20
- Average True Range (ATR)
- ETON 0.92
- BCAL 0.45
- MACD
- ETON 0.06
- BCAL 0.20
- Stochastic Oscillator
- ETON 73.09
- BCAL 87.55
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through strong partnerships with its clients.